Dana Pizzuti Crinetics Pharmaceuticals, Inc. (CRNX) insider trading activity
Dana Pizzuti is Chief Med and Dev Officer of Crinetics Pharmaceuticals, Inc.. Currently has a direct ownership of 74,748 shares of CRNX, which is worth approximately $2.55 Million. The most recent transaction as insider was on Oct 10, 2022, when has been sold 12,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
74.7K
162.21%
3M change
158.55%
12M change
Total Value Held
$2.55 Million
DP
Dana Pizzuti
Chief Med and Dev Officer
San Diego, CA